Approval · Notice of Compliance 957 · 2000
PROLEUKIN: Notice of Compliance 957
Issued June 12, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 957
- Date
- June 12, 2000
- Company
- Chiron Corporation
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing-increase in final product lot size, -change in stability testing programme
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLEUKIN | Not yet assigned | — |
Medicinal ingredients
- ALDESLEUKIN 22,000,000 UNIT per VIAL